{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:25:41Z","timestamp":1791869141511,"version":"4.3.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007391","name":"Association pour la Recherche sur le Cancer","doi-asserted-by":"crossref","award":["3154"],"award-info":[{"award-number":["3154"]}],"id":[{"id":"10.13039\/100007391","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ijrobp.2014.04.026","type":"journal-article","created":{"date-parts":[[2014,7,8]],"date-time":"2014-07-08T09:02:25Z","timestamp":1404810145000},"page":"1047-1052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Role of FDG-PET in the Implementation of Involved-Node Radiation Therapy for Hodgkin Lymphoma Patients"],"prefix":"10.1016","volume":"89","author":[{"given":"Th\u00e9odore","family":"Girinsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Aup\u00e9rin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Ribrag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Elleuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Ferm\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0054-5898","authenticated-orcid":false,"given":"Guillaume","family":"Bonniaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Ruelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Alberini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aljosa","family":"Celebic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Edeline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.ijrobp.2014.04.026_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/annonc\/13.S1.79","article-title":"The involved field is back: issues in delineating the radiation field in Hodgkin's disease","volume":"13","author":"Yahalom","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2014.04.026_bib2","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1200\/JCO.2008.19.9174","article-title":"Breast cancer risk in female survivors of Hodgkin\u2019s lymphoma: lower risk after smaller radiation volumes","volume":"27","author":"De Bruin","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.04.026_bib3","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","article-title":"Long-term cause-specific mortality of patients treated for Hodgkin disease","volume":"21","author":"Aleman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.04.026_bib4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.radonc.2006.05.015","article-title":"on behalf of the EORTC-GELA Lymphoma Group. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines","volume":"79","author":"Girinsky","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2014.04.026_bib5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.radonc.2008.05.012","article-title":"on behalf of the EORTC-GELA Lymphoma Group. The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines","volume":"88","author":"Girinsky","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2014.04.026_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijrobp.2012.02.023","article-title":"Are we ready for positron emission tomography\/computed tomography-based target volume definition in lymphoma radiation therapy?","volume":"85","author":"Yeoh","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.04.026_bib7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.radonc.2007.07.003","article-title":"Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting?","volume":"85","author":"Girinsky","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2014.04.026_bib8","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1182\/blood-2007-06-097238","article-title":"The role of FDG-PET scans in patients with lymphoma","volume":"110","author":"Seam","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2014.04.026_bib9","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.04.026_bib10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.04.026_bib11","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1200\/JCO.2009.22.4089","article-title":"Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trials","volume":"27","author":"Meignan","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.04.026_bib12","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1088\/0031-9155\/57\/17\/5381","article-title":"Impact of the accuracy of automatic tumour functional volume delineation on radiotherapy treatment planning","volume":"57","author":"Le Maitre","year":"2012","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2014.04.026_bib13","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00259-011-2053-0","article-title":"Comparative methods for PET image segmentation in pharyngolaryngeal squamous cell carcinoma","volume":"39","author":"Zaidi","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2014.04.026_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0167-8140(03)00270-6","article-title":"Tri-dimensional automatic segmentation of FDG-PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms","volume":"69","author":"Daisne","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2014.04.026_bib15","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1200\/JCO.2007.15.1001","article-title":"Involved nodal radiotherapy as a component of combination therapy for limited stage Hodgkin lymphoma: a question of field size","volume":"26","author":"Campbel","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.04.026_bib16","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00259-005-1784-1","article-title":"PET-CT with intravenous contrast can be used for PET attenuation correction in cancer patients","volume":"32","author":"Berthelsen","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2014.04.026_bib17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ijrobp.2010.06.044","article-title":"[18F]FDG-positron emission tomography coregistration with computed tomography scan for radiation treatment planning of lymphoma and hematologic malignancies","volume":"81","author":"Terezakis","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.04.026_bib18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ijrobp.2010.02.024","article-title":"Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition","volume":"80","author":"Metwally","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.04.026_bib19","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/pbc.23273","article-title":"Impact of PET-CT on involved field radiotherapy design for pediatric Hodgkin lymphoma","volume":"58","author":"Paulino","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2014.04.026_bib20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-0609.2006.00802.x","article-title":"Clinical impact of FDG-PET\/CT in the planning of radiotherapy for early stage Hodgkin lymphoma","volume":"78","author":"Hutchings","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ijrobp.2014.04.026_bib21","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMe1113291","article-title":"Chemotherapy alone for early-stage Hodgkin's lymphoma","volume":"366","author":"Straus","year":"2012","journal-title":"N Engl J Med"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301614004970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301614004970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T17:22:13Z","timestamp":1538414533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301614004970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0360301614004970"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2014.04.026","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of FDG-PET in the Implementation of Involved-Node Radiation Therapy for Hodgkin Lymphoma Patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2014.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}